The short version of obesity research fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-08-03. Anything still debated is marked as such rather than presented as settled.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C | Lyophilized peptide; protect from moisture and light. |
| Typical analytical method | HPLC and mass spectrometry | Used to confirm identity and estimate purity. |
| Common synonyms | AOD9604; hGH 176-191 | Naming varies by supplier and publication. |
| Disulfide bonds | One | Affects folded structure and stability. |
| Typical research purity | ≥95% | Value depends on supplier and analytical method. |
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
H3A (aq) + H2O (l) ⇌ H3O+ (aq) + H2A− (aq) Ka1 H2A− (aq) + H2O (l) ⇌ H3O+ (aq) + HA2− (aq) Ka2 HA2− (aq) + H2O (l) ⇌ H3O+ (aq) + A3− (aq) Ka3 An inorganic example of a triprotic acid is orthophosphoric acid (H3PO4), usually just called phosphoric acid. All three protons can be successively lost to yield H2PO−4, then HPO2−4, and finally PO3−4, the orthophosphate ion, usually just called phosphate. Even though the positions of the three protons on the original phosphoric acid molecule are equivalent, the successive Ka values differ since it is energetically less favorable to lose a proton if the conjugate base is more negatively charged. An organic example of a triprotic acid is citric acid, which can successively lose three protons to finally form the citrate ion. Although the subsequent loss of each hydrogen ion is less favorable, all of the conjugate bases are present in solution. The fractional concentration, α (alpha), for each species can be calculated. For example, a generic diprotic acid will generate 3 species in solution: H2A, HA−, and A2−. The fractional concentrations can be calculated as below when given either the pH (which can be converted to the [H+]) or the concentrations of the acid with all its conjugate bases:
NETA is a prodrug of norethisterone in the body. Upon oral ingestion, it is rapidly converted into norethisterone by esterases during intestinal and first-pass hepatic metabolism. Hence, as a prodrug of norethisterone, NETA has essentially the same effects, acting as a potent progestogen with additional weak androgenic and estrogenic activity (the latter via its metabolite ethinylestradiol).
Lawsuits against Merck & Co. regarding the marketing and use of Vioxx The landmark whistleblower case involving Neurontin (gabapentin) and off-label marketing: United States of America ex rel. David Franklin vs. Parke-Davis, Division of Warner-Lambert/Pfizer Investigations into conflict of interest and academic institutions by the US Senate Finance Committee, headed by Charles Grassley (R-Iowa) Investigations into the marketing of Vioxx to physicians by the United States House Committee on Oversight and Government Reform, headed by Henry A. Waxman Antitrust litigation involving Abbott Labs and their HIV/AIDS drug Norvir Lawsuits against Wyeth for the unethical promotion of the hormone replacement drug Premarin to women. Wyeth paid medical ghostwriters to author journal articles about the drug.
Sources: en.wikipedia.org
The study used a combination of existing, cheap drugs ahead of usual radiotherapy treatment. 24 October California-based startup Atom Computing announces a 1,225-qubit quantum computer, the first to break the 1,000+ barrier, which it plans to release in 2024. NASA provides updated details of its Nancy Grace Roman Space Telescope, planned for launch by 2027. JT-60SA, the world's largest fusion reactor, located in Japan, achieves first plasma. A study reviewing the 'planetary vital signs' reports deeply concerning patterns and records, minimal progress of mitigation by humanity, and a set of broad policy recommendations. It represents an annual update to a 2019 study that has been signed by now 15,000 researchers to track the state of climate change and its mitigation. 25 October – Scientists, helped by information derived from the Mars InSight lander, report that the planet Mars has a radioactive magma ocean under its crust. 26 October – Astronomers report studies that suggest for the first time that the planet Venus may have had plate tectonics during ancient times, and, as a result, may have had a cooler more habitable environment, and possibly one capable of generating life forms. 28 October – Positive results are reported in a study with rats of the experimental vaccine calixcoca meant for treating cocaine addiction. Clinical trials in humans are the next step of the study.
=== Cuisine === Ghanaian cuisine includes an assortment of soups and stews with varied seafoods; most Ghanaian soups are prepared with vegetables, meat, poultry or fish. Fish is in the diet with tilapia, roasted and fried whitebait, smoked fish and crayfish, all being components of Ghanaian dishes. Banku (akple) is a starchy food made from ground corn (maize), and cornmeal based staples kɔmi (kenkey) and banku (akple) may be accompanied by some form of fried fish (chinam) or grilled tilapia and a spicy condiment made from raw red and green chillies, onions and tomatoes (pepper sauce). Banku and tilapia is a combo served in some restaurants. Fufu is the most common exported Ghanaian dish and is a delicacy across the African diaspora. Rice is an established staple meal across the country, with various rice-based dishes serving as breakfast, lunch and dinner, the main variants are waakye, plain rice and stew (either kontomire or tomato gravy), fried rice and jollof rice.
A moving average measurement may also be used, in which the average results for patient samples are measured at certain intervals. Assuming that the characteristics of the patient population remain roughly the same over time, the average should remain constant. Large shifts in the average value can indicate instrument problems.
Sources: en.wikipedia.org
== Technological achievements == In addition to being credited with the development of one of the first anti-virus programs, "Vaccine", Tippett pioneered and commercialized a string of now-common technologies including what is now called the "Recovery Disk," processor image signatures, using hash-tables for trusted file execution and anomaly detection, aspects of mail merge and "un-do." He ran a bulletin board system for CP/M software before the first IBM PC was created and was president of the Cleveland Osborne Group (a user group for the computers of the Osborne Computer Corporation) in the early 1980s. As chief scientist for ICSA.net, Tippett was one of a handful of experts to identify and address the ILOVEYOU virus that broke in May 2000 and provided key information to the Department of Justice about David Smith, the writer of the Melissa virus. He was featured on the cover of the August 2000 issue of Time Digital magazine.
=== Reggio revolt === The Reggio revolt came on 14 July 1970, supported across social classes (bourgeoisie, clergy, students, political parties, civic committees). Clashes with authorities left one dead (railroad worker Bruno Labate), prompting Archbishop Vincenzo Ferro to join the showdown. The uprising was supported by liberal-conservative newspapers (such as Gazzetta del Sud and Il Tempo). Gradually protest leadership passed from Mayor Battaglia, to more assertive movements, particularly the Movimento Sociale Italiano, seen as least compromised with the republican regime. The Missini authored slogans (famous was the boia chi molla of D'Annunzian memory). Ciccio Franco, a CISNAL trade unionist and Reggio Calabria-based Missini exponent, emerged as the undisputed leader. Barricades were erected, the railway station was occupied and convoys and ferries to Sicily were blocked. Nineteen days of general strikes, 12 bomb attacks, 32 roadblocks, 14 occupations of the station, 2 of the post office, 1 of the television station, and 4 assaults on the prefecture, The death toll reached 5 on both sides (in addition to Labate, Angelo Campanella, also perished in the clashes, Vincenzo Curigliano, Antonio Bellotti, and Carmelo Jaconis). 426 were arrested and 200 were wounded during police charges (whose members were insulted and vilified even by hospital doctors). In some parts of the city, “autonomous republics” were proclaimed, such as the “Republic of Sbarre” and the “Grand Duchy of St. Catherine”.
==== Faroe Islands ==== On 21 November 2025, Danish Defence Minister Troels Lund Poulsen visited the Faroe Islands, where both parties discussed Faroese participation regarding the situation in Greenland. Faroese Speaker of the Løgting Bjørt Samuelsen sent an official letter of support to their Greenlandic counterpart, Kim Kielsen. Denmark and NATO did not deploy troops to the Faroe Islands as part of Operation Arctic Endurance.
Sources: en.wikipedia.org
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.
The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.
It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.